Q
QIAGEN N.V.
QGENCIK 0001015820NYSELarge AcceleratedBiological Products, (No Diagnostic Substances)P7NLFY ends Dec 31
Period
FY 2025
Revenue
$2.09B
Net Income
$424.88M
Total Assets
$6.28B
Equity
$3.78B
Shares Out
216.92M
Op. Cash Flow
$654.33M
Business
QIAGEN N.V. is a foreign private issuer in Biological Products, (No Diagnostic Substances), headquartered in the Netherlands. Shares trade on NYSE under the ticker QGEN.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $2.09B |
| Net income | $424.88M |
| Total assets | $6.28B |
| Total liabilities | — |
| Stockholders' equity | $3.78B |
| Operating cash flow | $654.33M |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro